Zacks.com on MSN2d
Catalent Stock Flat Following the Sell Agreement With ArdenaCTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.
Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, ...
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch ...
Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on Monday.
Oct. 17, 2024 — A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile ...
合同制造服务提供商Catalent已达成协议，将其位于新泽西州萨默塞特的口服药物开发和小规模制造工厂出售给私人合同药品制造商Ardena。该交易于今日宣布。 这座获得美国食品和药物管理局(FDA)批准的萨默塞特工厂拥有约200名科学家和技术人员。Ardena表示，收购这座工厂将增强其在口服药物商业化生产方面的能力。 Catalent以其灌装完成工作而闻名，包括为制药公司进行注射器和注射笔的无菌灌装 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback